Skip to main content
Clinical Trials/NL-OMON28370
NL-OMON28370
Completed
Phase 3

Personalized hearing aids to ameliorate tinnitus

niversity Medical Center Groningen0 sites18 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
<p>Tinnitus</p>
Sponsor
niversity Medical Center Groningen
Enrollment
18
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: \- No reported neurological or psychiatric disorders (excluding tinnitus and hearing loss); \- High frequency hearing loss; \- Moderate\- to moderate\-severe\- degree of hearing loss (PTA of 1, 2 and 4 kHz \= 35 dB); \- Chronic tinnitus (lasting more than 6 months); \- Tinnitus percept described as tonal (or at least being able to perceive a pitch during a tinnitus matching); \- Tinnitus pitch \= 6 kHz, and in the hearing loss region; \- Using hearing aids for at least the last 6 months; \- Written informed consent;

Exclusion Criteria

  • Non\-conformance to any of the inclusion criteria stated above;

Outcomes

Primary Outcomes

Not specified

Similar Trials